343 related articles for article (PubMed ID: 36975758)
21. Tumor-targeted nanomedicines for cancer theranostics.
Arranja AG; Pathak V; Lammers T; Shi Y
Pharmacol Res; 2017 Jan; 115():87-95. PubMed ID: 27865762
[TBL] [Abstract][Full Text] [Related]
22. Nanotechnology in Tuberculosis: State of the Art and the Challenges Ahead.
Grotz E; Tateosian N; Amiano N; Cagel M; Bernabeu E; Chiappetta DA; Moretton MA
Pharm Res; 2018 Sep; 35(11):213. PubMed ID: 30238168
[TBL] [Abstract][Full Text] [Related]
23. Addressing the challenges to increase the efficiency of translating nanomedicine formulations to patients.
Bhattacharjee S; Brayden DJ
Expert Opin Drug Discov; 2021 Mar; 16(3):235-254. PubMed ID: 33108229
[TBL] [Abstract][Full Text] [Related]
24. Combination antitumor therapy with targeted dual-nanomedicines.
Dai W; Wang X; Song G; Liu T; He B; Zhang H; Wang X; Zhang Q
Adv Drug Deliv Rev; 2017 Jun; 115():23-45. PubMed ID: 28285944
[TBL] [Abstract][Full Text] [Related]
25. Nano-based drug delivery system for therapeutics: a comprehensive review.
Prakash S
Biomed Phys Eng Express; 2023 Aug; 9(5):. PubMed ID: 37549657
[TBL] [Abstract][Full Text] [Related]
26. Nanomedicines for kidney diseases.
Williams RM; Jaimes EA; Heller DA
Kidney Int; 2016 Oct; 90(4):740-5. PubMed ID: 27292222
[TBL] [Abstract][Full Text] [Related]
27. Nanomedicine for Treatment of Lung Cancer.
Hussain S
Adv Exp Med Biol; 2016; 890():137-47. PubMed ID: 26703803
[TBL] [Abstract][Full Text] [Related]
28. Nanomedicines: Redefining traditional medicine.
Lu W; Yao J; Zhu X; Qi Y
Biomed Pharmacother; 2021 Feb; 134():111103. PubMed ID: 33338747
[TBL] [Abstract][Full Text] [Related]
29. Recent trends of nanomedicinal approaches in clinics.
Dilnawaz F; Acharya S; Sahoo SK
Int J Pharm; 2018 Mar; 538(1-2):263-278. PubMed ID: 29339248
[TBL] [Abstract][Full Text] [Related]
30. Recent advances in nanomaterials for neural applications: opportunities and challenges.
Sisubalan N; Shalini R; Ramya S; Sivamaruthi BS; Chaiyasut C
Nanomedicine (Lond); 2023 Nov; 18(26):1979-1994. PubMed ID: 38078433
[TBL] [Abstract][Full Text] [Related]
31. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
32. Specific targeting cancer cells with nanoparticles and drug delivery in cancer therapy.
Raj S; Khurana S; Choudhari R; Kesari KK; Kamal MA; Garg N; Ruokolainen J; Das BC; Kumar D
Semin Cancer Biol; 2021 Feb; 69():166-177. PubMed ID: 31715247
[TBL] [Abstract][Full Text] [Related]
33. Targeting Brain Tumors with Nanomedicines: Overcoming Blood Brain Barrier Challenges.
Khaitan D; Reddy PL; Ningaraj N
Curr Clin Pharmacol; 2018; 13(2):110-119. PubMed ID: 29651960
[TBL] [Abstract][Full Text] [Related]
34. Polymeric nanoparticles in development for treatment of pulmonary infectious diseases.
Lim YH; Tiemann KM; Hunstad DA; Elsabahy M; Wooley KL
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2016 Nov; 8(6):842-871. PubMed ID: 27016134
[TBL] [Abstract][Full Text] [Related]
35. Nanomedicines for the treatment of hematological malignancies.
Deshantri AK; Varela Moreira A; Ecker V; Mandhane SN; Schiffelers RM; Buchner M; Fens MHAM
J Control Release; 2018 Oct; 287():194-215. PubMed ID: 30165140
[TBL] [Abstract][Full Text] [Related]
36. Nanomedicine for the management of lung and blood diseases.
Buxton DB
Nanomedicine (Lond); 2009 Apr; 4(3):331-9. PubMed ID: 19331540
[TBL] [Abstract][Full Text] [Related]
37. Harnessing inhaled nanoparticles to overcome the pulmonary barrier for respiratory disease therapy.
Jin Z; Gao Q; Wu K; Ouyang J; Guo W; Liang XJ
Adv Drug Deliv Rev; 2023 Nov; 202():115111. PubMed ID: 37820982
[TBL] [Abstract][Full Text] [Related]
38. Nano-Therapeutics for the Lung: State-of-the-Art and Future Perspectives.
Iyer R; Hsia CC; Nguyen KT
Curr Pharm Des; 2015; 21(36):5233-44. PubMed ID: 26412358
[TBL] [Abstract][Full Text] [Related]
39. Advances and challenges in nanocarriers and nanomedicines for veterinary application.
Carvalho SG; Araujo VHS; Dos Santos AM; Duarte JL; Silvestre ALP; Fonseca-Santos B; Villanova JCO; Gremião MPD; Chorilli M
Int J Pharm; 2020 Apr; 580():119214. PubMed ID: 32165220
[TBL] [Abstract][Full Text] [Related]
40. Nanotechnology in therapeutics: a focus on nanoparticles as a drug delivery system.
Bamrungsap S; Zhao Z; Chen T; Wang L; Li C; Fu T; Tan W
Nanomedicine (Lond); 2012 Aug; 7(8):1253-71. PubMed ID: 22931450
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
